This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jin, L. Articles by Lloyd, R. V. Search for Related Content PubMed PubMed Citation Articles by Jin, L. Articles by Lloyd, R. V.

American Journal of Pathology, Vol 138, 961-969, Copyright © 1991 by American Society for Investigative Pathology

REGULAR ARTICLES

Expression of neural cell adhesion molecule in normal and neoplastic human neuroendocrine tissues

L Jin, JJ Hemperly and RV Lloyd
Department of Pathology, University of Michigan, Ann Arbor.

The neural cell adhesion molecule (N-CAM) is a group of cell surface glycoproteins involved in direct cell--cell adhesion. N-CAM expression in normal and neoplastic tissues was examined with specific antibodies and oligonucleotide probes by immunohistochemistry and in situ hybridization. Most neuroendocrine cells and tumors with secretory granules expressed N-CAM protein and mRNA. Parathyroid adenomas (4) were somewhat unusual, because N-CAM mRNA, but not protein, was detected in some of these benign neoplasms. Most non-neuroendocrine cells and tumors did not express N-CAM, although uterine smooth muscle and an adrenal cortical carcinoma were both positive. Western blots disclosed proteins of 180, 140, and 120 kd in normal adult brain, whereas two pheochromocytomas, a null cell adenoma, and a gastrinoma had proteins of approximately 180 and 140 kd. These results indicate that N-CAM protein and mRNA are widely expressed in neuroendocrine cells and neoplasms. N-CAM oligonucleotide probes as well as antibodies against N-CAM can be used as broad-spectrum neuroendocrine markers. In addition, these molecular probes can be used to examine the role of N- CAM in the development and regulation of neuroendocrine tissues.

This article has been cited by other articles:

				S. Gattenloehner, S. Chuvpilo, C. Langebrake, D. Reinhardt, H.-K. Muller-Hermelink, E. Serfling, A. Vincent, and A. Marx Novel RUNX1 isoforms determine the fate of acute myeloid leukemia cells by controlling CD56 expression Blood, September 15, 2007; 110(6): 2027 - 2033. [Abstract] [Full Text] [PDF]

				A. Gurlek, N. Karavitaki, O. Ansorge, and J. A H Wass What are the markers of aggressiveness in prolactinomas? Changes in cell biology, extracellular matrix components, angiogenesis and genetics Eur. J. Endocrinol., February 1, 2007; 156(2): 143 - 153. [Abstract] [Full Text] [PDF]

				K Kontogianni, A G Nicholson, D Butcher, and M N Sheppard CD56: a useful tool for the diagnosis of small cell lung carcinomas on biopsies with extensive crush artefact J. Clin. Pathol., September 1, 2005; 58(9): 978 - 980. [Abstract] [Full Text] [PDF]

				H.-W. Chen, S.-L. Yu, J. J. W. Chen, H.-N. Li, Y.-C. Lin, P.-L. Yao, H.-Y. Chou, C.-T. Chien, W.-J. Chen, Y.-T. Lee, et al. Anti-Invasive Gene Expression Profile of Curcumin in Lung Adenocarcinoma Based on a High Throughput Microarray Analysis Mol. Pharmacol., January 1, 2004; 65(1): 99 - 110. [Abstract] [Full Text] [PDF]

				M. O. Muench, J. V. Ratcliffe, M. Nakanishi, H. Ishimoto, and R. B. Jaffe Isolation of Definitive Zone and Chromaffin Cells Based upon Expression of CD56 (Neural Cell Adhesion Molecule) in the Human Fetal Adrenal Gland J. Clin. Endocrinol. Metab., August 1, 2003; 88(8): 3921 - 3930. [Abstract] [Full Text] [PDF]